Nationwide Fund Advisors’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-51,678
| Closed | -$1.93M | – | 2527 |
|
|
2017
Q3 | $1.93M | Buy |
51,678
+26,941
| +109% | +$1.01M | 0.01% | 1459 |
|
|
2017
Q2 | $752K | Buy |
24,737
+2,000
| +9% | +$60.8K | ﹤0.01% | 1951 |
|
|
2017
Q1 | $602K | Buy |
22,737
+2,168
| +11% | +$57.4K | ﹤0.01% | 2053 |
|
|
2016
Q4 | $525K | Sell |
20,569
-982
| -5% | -$25.1K | ﹤0.01% | 2156 |
|
|
2016
Q3 | $780K | Sell |
21,551
-4,400
| -17% | -$159K | ﹤0.01% | 1933 |
|
|
2016
Q2 | $882K | Buy |
25,951
+2,077
| +9% | +$70.6K | ﹤0.01% | 1806 |
|
|
2016
Q1 | $630K | Buy |
23,874
+9,621
| +68% | +$254K | ﹤0.01% | 1967 |
|
|
2015
Q4 | $695K | Buy |
14,253
+208
| +1% | +$10.1K | ﹤0.01% | 1921 |
|
|
2015
Q3 | $350K | Sell |
14,045
-3,500
| -20% | -$87.2K | ﹤0.01% | 2300 |
|
|
2015
Q2 | $555K | Buy |
17,545
+5,495
| +46% | +$174K | ﹤0.01% | 2192 |
|
|
2015
Q1 | $459K | Sell |
12,050
-453
| -4% | -$17.3K | ﹤0.01% | 2281 |
|
|
2014
Q4 | $487K | Sell |
12,503
-153
| -1% | -$5.96K | ﹤0.01% | 2201 |
|
|
2014
Q3 | $383K | Buy |
12,656
+40
| +0.3% | +$1.21K | ﹤0.01% | 2356 |
|
|
2014
Q2 | $429K | Buy |
12,616
+7,140
| +130% | +$243K | ﹤0.01% | 2347 |
|
|
2014
Q1 | $189K | Buy |
5,476
+588
| +12% | +$20.3K | ﹤0.01% | 2506 |
|
|
2013
Q4 | $194K | Buy |
+4,888
| New | +$194K | ﹤0.01% | 2702 |
|